NB200111UV

p14ARF/CDKN2A Antibody, DyLight 350, Novus Biologicals™

Manufacturer: Novus Biologicals

Select a Size

Pack Size SKU Availability Price
Each of 1 NB200111UV-Each-of-1 In Stock ₹ 53,218.32

NB200111UV - Each of 1

₹ 53,218.32

In Stock

Quantity

1

Base Price: ₹ 53,218.32

GST (18%): ₹ 9,579.298

Total Price: ₹ 62,797.618

Antigen

p14ARF/CDKN2A

Classification

Polyclonal

Conjugate

DyLight 350

Formulation

PBS with 0.05% Sodium Azide

Gene Symbols

CDKN2A

Immunogen

A synthetic peptide made to a portion of human p14ARF (between residues 50-150). [Swiss-Prot# Q8N726]

Quantity

0.1 mL

Research Discipline

ABC Transporters, Cancer, Cell Biology, Cell Cycle and Replication, Chromatin Research, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, Transcription Factors and Regulators, Tumor Suppressors

Gene ID (Entrez)

1029

Content And Storage

Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.

Applications

Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), KnockDown

Concentration

1.0 mg/mL

Dilution

Western Blot, Flow Cytometry 1:400, ELISA 1:100 - 1:2000, Immunohistochemistry, Immunocytochemistry/Immunofluorescence 1:50 - 1:200, Immunohistochemistry-Paraffin 1:10 - 1:500, Immunohistochemistry-Frozen 1:10 - 1:500, KnockDown Validated

Gene Alias

ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, P16, p16-INK4, p16-INK4a, P16INK4A, P19, p19Arf, TP16

Host Species

Rabbit

Purification Method

Affinity Purified

Regulatory Status

RUO

Primary or Secondary

Primary

Target Species

Human, Mouse

Isotype

IgG

Related Products

Img

Novus Biologicals

NB200111B

--

Img

Novus Biologicals

NB200106H

--

Img

Novus Biologicals

NB497325

--

Img

Novus Biologicals

NB497324

--

Img

Novus Biologicals

NB318490

--

Img

Novus Biologicals

NB318489

--

Img

Novus Biologicals

NB11059085C

--

Img

Novus Biologicals

NB382569

--

Description

  • Description p14ARF/CDKN2A Polyclonal specifically detects p14ARF/CDKN2A in Human, Mouse samples
  • It is validated for Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Knockdown Validated.

Compare Similar Items

Show Difference

Img

Novus Biologicals

NB200111UV

--


Antigen:
p14ARF/CDKN2A

Classification:
Polyclonal

Conjugate:
DyLight 350

Formulation:
PBS with 0.05% Sodium Azide

Gene Symbols:
CDKN2A

Immunogen:
A synthetic peptide made to a portion of human p14ARF (between residues 50-150). [Swiss-Prot# Q8N726]

Quantity:
0.1 mL

Research Discipline:
ABC Transporters, Cancer, Cell Biology, Cell Cycle and Replication, Chromatin Research, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, Transcription Factors and Regulators, Tumor Suppressors

Gene ID (Entrez):
1029

Content And Storage:
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.

Applications:
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), KnockDown

Concentration:
1.0 mg/mL

Dilution:
Western Blot, Flow Cytometry 1:400, ELISA 1:100 - 1:2000, Immunohistochemistry, Immunocytochemistry/Immunofluorescence 1:50 - 1:200, Immunohistochemistry-Paraffin 1:10 - 1:500, Immunohistochemistry-Frozen 1:10 - 1:500, KnockDown Validated

Gene Alias:
ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, P16, p16-INK4, p16-INK4a, P16INK4A, P19, p19Arf, TP16

Host Species:
Rabbit

Purification Method:
Affinity Purified

Regulatory Status:
RUO

Primary or Secondary:
Primary

Target Species:
Human, Mouse

Isotype:
IgG

Img

Novus Biologicals

NB200111X

--


Antigen:
p14ARF/CDKN2A

Classification:
Polyclonal

Conjugate:
Alexa Fluor 488

Formulation:
50mM Sodium Borate with 0.05% Sodium Azide

Gene Symbols:
CDKN2A

Immunogen:
A synthetic peptide made to a portion of human p14ARF (between residues 50-150). [Swiss-Prot# Q8N726]

Quantity:
0.1 mL

Research Discipline:
ABC Transporters, Cancer, Cell Biology, Cell Cycle and Replication, Chromatin Research, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, Transcription Factors and Regulators, Tumor Suppressors

Gene ID (Entrez):
1029

Content And Storage:
Store at 4C in the dark.

Applications:
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), KnockDown

Concentration:
__

Dilution:
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, KnockDown Validated

Gene Alias:
ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, P16, p16-INK4, p16-INK4a, P16INK4A, P19, p19Arf, TP16

Host Species:
Rabbit

Purification Method:
Affinity Purified

Regulatory Status:
RUO

Primary or Secondary:
Primary

Target Species:
Human, Mouse

Isotype:
IgG

Img

Novus Biologicals

NB200111Y

--


Antigen:
p14ARF/CDKN2A

Classification:
Polyclonal

Conjugate:
Alexa Fluor 647

Formulation:
50mM Sodium Borate with 0.05% Sodium Azide

Gene Symbols:
CDKN2A

Immunogen:
A synthetic peptide made to a portion of human p14ARF (between residues 50-150). [Swiss-Prot# Q8N726]

Quantity:
0.1 mL

Research Discipline:
ABC Transporters, Cancer, Cell Biology, Cell Cycle and Replication, Chromatin Research, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, Transcription Factors and Regulators, Tumor Suppressors

Gene ID (Entrez):
1029

Content And Storage:
Store at 4C in the dark.

Applications:
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), KnockDown

Concentration:
__

Dilution:
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, KnockDown Validated

Gene Alias:
ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, P16, p16-INK4, p16-INK4a, P16INK4A, P19, p19Arf, TP16

Host Species:
Rabbit

Purification Method:
Affinity Purified

Regulatory Status:
RUO

Primary or Secondary:
Primary

Target Species:
Human, Mouse

Isotype:
IgG

Img

Novus Biologicals

NB200111Z

--


Antigen:
p14ARF/CDKN2A

Classification:
Polyclonal

Conjugate:
Alexa Fluor 700

Formulation:
50mM Sodium Borate with 0.05% Sodium Azide

Gene Symbols:
CDKN2A

Immunogen:
A synthetic peptide made to a portion of human p14ARF (between residues 50-150). [Swiss-Prot# Q8N726]

Quantity:
0.1 mL

Research Discipline:
ABC Transporters, Cancer, Cell Biology, Cell Cycle and Replication, Chromatin Research, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, Transcription Factors and Regulators, Tumor Suppressors

Gene ID (Entrez):
1029

Content And Storage:
Store at 4C in the dark.

Applications:
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), KnockDown

Concentration:
__

Dilution:
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, KnockDown Validated

Gene Alias:
ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, P16, p16-INK4, p16-INK4a, P16INK4A, P19, p19Arf, TP16

Host Species:
Rabbit

Purification Method:
Affinity Purified

Regulatory Status:
RUO

Primary or Secondary:
Primary

Target Species:
Human, Mouse

Isotype:
IgG